TickerFacts.

RxSight, Inc. (RXST): Shareholders' Equity

Annual figures by period end, from SEC filings.

$275.68M
As of 2025-12-31
$263.34M
As of 2026-06-30
+45.3%
3-year compound annual growth
$281.24M2020-12-31: -$430.59M2021-12-31: $138.24M2022-12-31: $89.90M2023-12-31: $160.36M2024-12-31: $281.24M2025-12-31: $275.68M$275.68M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$275.68M-2.0%2026-02-25, Balance as of period end
2024-12-31$281.24M+75.4%2026-02-25, Balance as of period end
2023-12-31$160.36M+78.4%2025-02-25, Balance as of period end
2022-12-31$89.90M-35.0%2024-02-28, Balance as of period end
2021-12-31$138.24Mn/m2023-03-06, Balance as of period end
2020-12-31-$430.59Mn/a2022-03-08, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
RxSight, Inc. (RXST)2025-12-31$275.68M-2.0%
Staar Surgical Co (STAA)2026-01-02$344.18M-13.4%
Warby Parker Inc. (WRBY)2025-12-31$367.73M+8.1%
National Vision Holdings, Inc. (EYE)2026-01-03$869.53M+6.5%
Cooper Companies, Inc. (COO)2025-10-31$8.24B+1.9%
Bausch & Lomb Corp (BLCO)2025-12-31$6.52B-0.4%
Innovative Eyewear Inc (LUCY)2025-12-31$9.07M-0.3%

Compare RXST, STAA, WRBY, EYE side by side · Screen every company in Ophthalmic Goods ↗